| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1001020138 |
| P356 | DOI | 10.1186/BCR3236 |
| P932 | PMC publication ID | 3680939 |
| P698 | PubMed publication ID | 22839103 |
| P5875 | ResearchGate publication ID | 230574956 |
| P50 | author | Olli-Pekka Kallioniemi | Q29949182 |
| Markus Ringnér | Q37374913 | ||
| P2093 | author name string | Ake Borg | |
| Johan Staaf | |||
| Erik Fredlund | |||
| Juha K Rantala | |||
| P2860 | cites work | Gene ontology: tool for the unification of biology | Q23781406 |
| Cytoscape: a software environment for integrated models of biomolecular interaction networks | Q24515682 | ||
| Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles | Q24536351 | ||
| Genomic subtypes of breast cancer identified by array-comparative genomic hybridization display distinct molecular and clinical characteristics | Q24595882 | ||
| A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes | Q24647928 | ||
| Expression profiling to predict outcome in breast cancer: the influence of sample selection | Q24795022 | ||
| Basal cytokeratins and their relationship to the cellular origin and functional classification of breast cancer | Q24810751 | ||
| Epithelial-mesenchymal transitions in tumour progression | Q27860487 | ||
| Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications | Q27860709 | ||
| Gene expression profiling predicts clinical outcome of breast cancer | Q27860732 | ||
| Network biology: understanding the cell's functional organization | Q27861027 | ||
| Molecular portraits of human breast tumours | Q28032461 | ||
| Gene expression-based classification of non-small cell lung carcinomas and survival prediction | Q28395058 | ||
| BiNGO: a Cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks | Q29547427 | ||
| The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups | Q29614700 | ||
| Supervised risk predictor of breast cancer based on intrinsic subtypes | Q29617404 | ||
| Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer | Q29619481 | ||
| Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features | Q29620020 | ||
| Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer | Q37198196 | ||
| Early transcriptional events in cell growth: the Egr family | Q37835875 | ||
| Methylation profiling with a panel of cancer related genes: association with estrogen receptor, TP53 mutation status and expression subtypes in sporadic breast cancer | Q38503758 | ||
| Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype | Q40012189 | ||
| Breast cancer molecular profiling with single sample predictors: a retrospective analysis | Q42467730 | ||
| Identification of subtypes in human epidermal growth factor receptor 2--positive breast cancer reveals a gene signature prognostic of outcome | Q42468745 | ||
| Identification of molecular apocrine breast tumours by microarray analysis. | Q42478400 | ||
| Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer | Q42499457 | ||
| Distinct p53 gene signatures are needed to predict prognosis and response to chemotherapy in ER-positive and ER-negative breast cancers | Q43546960 | ||
| Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns | Q43708523 | ||
| Understanding Adipocyte Differentiation | Q46119331 | ||
| Systems genetics analysis of cancer susceptibility: from mouse models to humans | Q46196856 | ||
| Gene expression profiling-based identification of molecular subtypes in stage IV melanomas with different clinical outcome | Q48661799 | ||
| A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers | Q51584233 | ||
| Increased expression of mitotic checkpoint genes in breast cancer cells with chromosomal instability | Q53639627 | ||
| Biological Processes Associated with Breast Cancer Clinical Outcome Depend on the Molecular Subtypes | Q57660183 | ||
| TP53 genomics predict higher clinical and pathologic tumor response in operable early-stage breast cancer treated with docetaxel-capecitabine ± trastuzumab | Q59565353 | ||
| Development and clinical utility of a 21-gene recurrence score prognostic assay in patients with early breast cancer treated with tamoxifen | Q80548296 | ||
| Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis | Q30004190 | ||
| Tackling the widespread and critical impact of batch effects in high-throughput data | Q30004214 | ||
| High levels of the Mps1 checkpoint protein are protective of aneuploidy in breast cancer cells | Q30499296 | ||
| A cell spot microarray method for production of high density siRNA transfection microarrays | Q30499422 | ||
| The molecular portraits of breast tumors are conserved across microarray platforms | Q33241398 | ||
| Stromal gene expression predicts clinical outcome in breast cancer | Q33330931 | ||
| A signature-based method for indexing cell cycle phase distribution from microarray profiles | Q33424041 | ||
| Proliferation of aneuploid human cells is limited by a p53-dependent mechanism. | Q33643740 | ||
| LYN is a mediator of epithelial-mesenchymal transition and a target of dasatinib in breast cancer | Q33848195 | ||
| An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival | Q33939753 | ||
| Molecular subtypes of breast cancer are associated with characteristic DNA methylation patterns | Q34048118 | ||
| Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes | Q34100400 | ||
| Androgen receptor expression is inversely correlated with pathologic tumor stage in bladder cancer. | Q34339798 | ||
| An integrated approach to uncover drivers of cancer. | Q34453995 | ||
| FOXA1 is a key determinant of estrogen receptor function and endocrine response | Q34508204 | ||
| GOBO: gene expression-based outcome for breast cancer online | Q34704073 | ||
| Identification of fusion genes in breast cancer by paired-end RNA-sequencing | Q34964405 | ||
| Paradoxical relationship between chromosomal instability and survival outcome in cancer | Q34988001 | ||
| Molecular portraits and the family tree of cancer | Q35010198 | ||
| Mad2 is a critical mediator of the chromosome instability observed upon Rb and p53 pathway inhibition. | Q35059874 | ||
| Genetic architecture of mouse skin inflammation and tumour susceptibility | Q35702641 | ||
| A refined molecular taxonomy of breast cancer | Q35838290 | ||
| Gene signature evaluation as a prognostic tool: challenges in the design of the MINDACT trial | Q36613514 | ||
| An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer | Q36643153 | ||
| High Myc pathway activity and low stage of neuronal differentiation associate with poor outcome in neuroblastoma | Q36893712 | ||
| A robust classifier of high predictive value to identify good prognosis patients in ER-negative breast cancer | Q36955150 | ||
| Mitotic checkpoints and the maintenance of the chromosome karyotype | Q37074588 | ||
| A comprehensive analysis of prognostic signatures reveals the high predictive capacity of the proliferation, immune response and RNA splicing modules in breast cancer | Q37131390 | ||
| P4510 | describes a project that uses | Cytoscape | Q3699942 |
| P433 | issue | 4 | |
| P304 | page(s) | R113 | |
| P577 | publication date | 2012-07-27 | |
| P1433 | published in | Breast Cancer Research | Q2208481 |
| P1476 | title | The gene expression landscape of breast cancer is shaped by tumor protein p53 status and epithelial-mesenchymal transition | |
| P478 | volume | 14 |
| Q38842480 | A Peroxidase Peroxiredoxin 1-Specific Redox Regulation of the Novel FOXO3 microRNA Target let-7. |
| Q59812972 | Adipocytes and Obesity-Related Conditions Jointly Promote Breast Cancer Cell Growth and Motility: Associations With CAP1 for Prognosis |
| Q36628822 | An integrated genomics analysis of epigenetic subtypes in human breast tumors links DNA methylation patterns to chromatin states in normal mammary cells. |
| Q28540922 | BDNF is associated with SFRP1 expression in luminal and basal-like breast cancer cell lines and primary breast cancer tissues: a novel role in tumor suppression? |
| Q37736572 | Breast tumor subgroups reveal diverse clinical prognostic power |
| Q30487940 | Circulating tumor cell clusters-associated gene plakoglobin and breast cancer survival |
| Q37619692 | Consensus of gene expression phenotypes and prognostic risk predictors in primary lung adenocarcinoma |
| Q34340016 | Development of a prognostic model for breast cancer survival in an open challenge environment. |
| Q34616600 | Distinct luminal-type mammary carcinomas arise from orthotopic Trp53-null mammary transplantation of juvenile versus adult mice |
| Q41136382 | Genome methylation patterns in male breast cancer - Identification of an epitype with hypermethylation of polycomb target genes |
| Q37388984 | Grading breast cancer tissues using molecular portraits |
| Q41657985 | IRF5 is a novel regulator of CXCL13 expression in breast cancer that regulates CXCR5(+) B- and T-cell trafficking to tumor-conditioned media |
| Q35828560 | Molecular stratification of metastatic melanoma using gene expression profiling: Prediction of survival outcome and benefit from molecular targeted therapy. |
| Q51593666 | RETRACTED ARTICLE: Targeted DNA methylation analysis explores association of adenocarcinoma and neuroendocrine epitypes with lung cancer |
| Q37600466 | SAP domain-dependent Mkl1 signaling stimulates proliferation and cell migration by induction of a distinct gene set indicative of poor prognosis in breast cancer patients |
| Q34632766 | Snail1 expression in colorectal cancer and its correlation with clinical and pathological parameters |
| Q58693733 | Sperm-Associated Antigen 5 Expression Is Increased in Hepatocellular Carcinoma and Indicates Poor Prognosis |
| Q39030842 | TP53 mutation-correlated genes predict the risk of tumor relapse and identify MPS1 as a potential therapeutic kinase in TP53-mutated breast cancers. |
| Q35032523 | The landscape of candidate driver genes differs between male and female breast cancer |
| Q38985973 | Transcriptional coexpression network reveals the involvement of varying stem cell features with different dysregulations in different gastric cancer subtypes |
Search more.